Seer Bio

Bewertungs-Analyse

Über das Unternehmen

Seer, Inc., a life sciences company, develops and commercializes products to decode the biology of the proteome to improve human health in the United States, China, Australia, Europe, Israel, Japan, and South Africa. The company offers Proteograph Product Suite, an integrated solution, which includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. The company also offers Proteograph ONE, a third-generation assay; Proteograph DIRECT, which provides an automated approach for direct digestion of samples for bottom-up LC-MS proteomic analysis; and Proteograph Analysis Suite, a data analytics software suite designed to su

Trading-Daten

Ähnliche Aktien aus dem Sektor

Wo kann ich Seer Bio kaufen?

Vergleiche die besten Broker — niedrige Gebühren, seriöse Anbieter, reguliert.